[An economic evaluation of measles vaccination in District 3 of the city of Bucharest].

Abstract

The cost-profit analysis (CPA) of the anti-measles (AM) vaccination, 10 years after its introduction in the anti-epidemic strategy, shows that in the district 3 of Bucharest, the prevention, by vaccination, of more than 17,000 cases of getting ill was associated with a net profit of 11 X 10(6) lei, and a profit/cost ratio (PCr) of 6/1. These figures evidence the economic value of the AM vaccination and stimulate the further development of the programme for the control of measles by vaccination.